BMJ Best Practice
最后审核时间： 十月 2018
最近更新时间： 六月 2018

小结

定义

病史和查体

关键诊断因素

  • 存在的危险因素
  • 幻听
  • 妄想
  • 意志力减退
全部具体信息

其他诊断因素

  • 行为怪异或紊乱的、紧张性的行为
  • 言不及义和联想松弛（脱轨）
  • 病理性赘述
  • 强制言语
全部具体信息

危险因素

  • 精神分裂症家族史
  • 父亲年龄较大
  • 产科并发症
  • 大麻使用
全部具体信息

诊断性检查

首要检查

  • 临床诊断
全部具体信息

需要考虑的检查

  • 头部 CT/MRI
  • 血清 HIV 酶联免疫吸附测定
  • 血清快速血浆反应素试验
  • 全血细胞计数 (FBC)
全部具体信息

治疗流程

推断

具有罹患精神病的风险

急性

急性精神病发作

疾病持续状态

长期症状

贡献者

作者 查看所有

Adrian Preda MD

Professor of Clinical Psychiatry

Department of Psychiatry and Human Behavior

University of California, Irvine School of Medicine

Irvine

CA

利益冲突披露
AP received a fee for consulting from Boehringer Ingelheim and a fee for speaking from Dainippon Sumitomo Pharma America, the manufacturer of lurasidone/Latuda.
Robert G. Bota MD

Associate Clinical Professor of Psychiatry

University of California

Irvine

CA

利益冲突披露
RGB declares that he has no competing interests.

Dr Adrian Preda and Dr Robert G. Bota would like to gratefully acknowledge Dr Manish Kumar, who assisted with research for this topic. MK declares that he has no competing interests.

同行评议专家 查看所有

Chief Pharmacist

South London and Maudsley NHS Foundation Trust

London

UK

利益冲突披露
DT declares that he has no competing interests.

Professor

Department of Psychiatry

University of New Mexico School of Medicine

Albuquerque

NM

利益冲突披露
JY declares that he has no competing interests.

Professor of Psychiatry

University of Missouri Kansas City

Kansas City

MO

利益冲突披露
KS declares that he has no competing interests.

使用此内容应接受我们的免责声明。